Healthcare Global Enterprises Share News - Latest Updates, Live News & More

Latest news about Healthcare Global Enterprises

HealthCare Global Enterprises Schedules Board Meeting for Rights Issue Consideration on February 17, 2026 8 days ago

HealthCare Global Enterprises Limited has scheduled a Board of Directors meeting for February 17, 2026, to consider a fund raise proposal through rights issue of equity shares. The meeting, announced on February 08, 2026, complies with Regulation 29 of SEBI Listing Regulations, with the proposal subject to applicable laws and regulatory approvals. The company has implemented a trading window closure for designated persons from February 09 through February 26, 2026, in accordance with insider trading prevention protocols.

Healthcare Global Enterprises Reports 13% Revenue Growth in Q3FY26 with Strong Margin Expansion 10 days ago

HealthCare Global Enterprises Board Approves Employee Stock Option Scheme 2026 Feb 05, 2026

HealthCare Global Enterprises Appoints Pankaj Gautam as Chief Information Officer Feb 05, 2026

HCG Updates Q3FY26 Investor Presentation with Clarifications Under Regulation 30 Feb 05, 2026

More news about Healthcare Global Enterprises

22Jan 26

Healthcare Global Enterprises Shareholders Approve Consultancy Arrangement Variations with Dr B.S. Ajaikumar

Healthcare Global Enterprises Limited shareholders approved variations to Dr B.S. Ajaikumar's consultancy arrangement through postal ballot with 98.32% favorable votes. The e-voting process saw 73.25% participation of total equity capital, with 238 members casting 10,32,84,703 valid votes. Results were declared on January 22, 2026, following scrutinizer V. Sreedharan's verification.

11Dec 25

Healthcare Global Enterprises CEO Presents Strategic Vision for Cancer Care Leadership

Healthcare Global Enterprises held a virtual investor meet on December 4, 2025, where CEO Dr. Manish Mattoo presented the company's strategic growth plan. Operating 25 hospitals across 19 cities with leadership in 16 markets, HCG achieved ₹2,200.00 crores revenue in FY2025 with 15% CAGR and industry-leading 0.90% mortality rate. The four-pillar strategy focuses on network optimization, strategic expansion, operational efficiency, and enhanced patient experience, targeting 21%-22% EBITDA margins and 20%+ ROCE over the next 3-5 years through ₹600-700 crores capex investment.

04Dec 25

HCG Unveils Ambitious Expansion Plans Amid Strong Financial Growth

Healthcare Global Enterprises (HCG), India's largest cancer care provider, announced plans to add 1,000 beds and 10 new Linear Accelerators over the next five years. The company aims for above-industry revenue growth, supported by strong financial performance. HCG's latest balance sheet shows significant growth in total assets (30.87% YoY) and fixed assets (38.89% YoY). As the market leader in India's cancer care sector, HCG is well-positioned to capitalize on growing healthcare demand in India and Africa.

01Dec 25

HCG Appoints Dr. Manish Mattoo as Interim CFO Amid Strong Financial Growth

Healthcare Global Enterprises Limited (HCG) has appointed Dr. Manish Mattoo, its Executive Director and CEO, as interim Chief Financial Officer effective December 01, 2025. This appointment comes during a period of robust financial growth for the company. HCG's total assets have increased by 30.87% year-over-year to ₹3,543.20 cr, with significant growth in fixed assets (38.89%) and current assets (24.11%). Dr. Mattoo, with over two decades of healthcare business leadership experience, will serve in this role until a new CFO is appointed by the Board of Directors.

13Nov 25

HealthCare Global Enterprises Approves INR 150 Crore Investment in Three Wholly Owned Subsidiaries

Healthcare Global Enterprises Limited (HCG) has approved investments totaling INR 150 crore in three of its wholly owned subsidiaries. HCG Kolkata Cancer Care LLP will receive INR 110 crore, HCG Oncology Hospitals LLP INR 15 crore, and HCG NCHRI Oncology LLP INR 25 crore. The investments are intended for repayment of dues, working capital, and general corporate purposes, to be completed by March 31, 2026. All three subsidiaries have shown consistent revenue growth over the past three years, with HCG maintaining 100% ownership in each.

12Nov 25

HCG Expands Footprint in Kenya with Strategic Investment and Loan Guarantee

Healthcare Global Enterprises Limited (HCG) has announced two strategic decisions to strengthen its presence in the African healthcare market. The company's board approved acquiring up to 10% shares in Cancer Care Kenya Limited (CCK) for up to INR 7.00 crore, to be completed by March 31, 2026. Additionally, HCG will issue a Standby Letter of Credit to secure a USD 1.8 million term loan for CCK's business expansion in Kenya. CCK operates a comprehensive cancer hospital in Nairobi and has shown significant growth, with revenue increasing from INR 9.07 crore to INR 42.53 crore.

12Nov 25

HealthCare Global Enterprises Appoints Manu Shankar Das as Chief Marketing Officer

Healthcare Global Enterprises Limited (HCG) has appointed Manu Shankar Das as its new Chief Marketing Officer, effective on or before December 20, 2025. Das brings over 15 years of cross-industry marketing experience, including healthcare, interior design, food & hospitality, travel, FMCG, and IT sectors. His expertise spans performance marketing, brand strategy, product marketing, digital marketing, and sales promotions. The appointment aims to strengthen HCG's marketing strategies and brand presence in the cancer care sector.

12Nov 25

HCG Enterprises Reports Q2 FY2026 Results, Approves Employee Stock Option Allotment

Healthcare Global Enterprises Limited (HCG) announced Q2 FY2026 results with revenue up 16.8% to ₹64,516 lakhs, but profit before tax down 28.3% to ₹1,982 lakhs. The company approved allotment of 7,537 equity shares under ESOP and investment of up to ₹700 lakhs in Cancer Care Kenya Limited. Board meeting held on November 12, 2025, approved unaudited financial results. BSR & Co. LLP conducted limited review with unmodified opinion.

12Nov 25

HealthCare Global Enterprises Approves Investment in Cancer Care Kenya and Outlines Multi-Year Growth Strategy

Healthcare Global Enterprises (HCG) has approved an investment of up to Rs. 700 lakhs in Cancer Care Kenya Limited, a step-down subsidiary. This strategic move aims to expand HCG's footprint in the African healthcare market. Cancer Care Kenya, operating in Nairobi, provides radiation and chemotherapy services. The company has shown significant growth, with revenue increasing from INR 90.73 crore in FY 2020-21 to INR 425.31 crore in FY 2022-23. The investment is subject to regulatory approvals and is part of HCG's multi-year growth strategy, which includes oncology expansion, clinical excellence, and leveraging digital health platforms.

04Nov 25

Motilal Oswal Mutual Fund Increases Stake in HealthCare Global Enterprises

Multiple schemes of Motilal Oswal Mutual Fund have increased their collective stake in Healthcare Global Enterprises Ltd from 4.93% to 5.04%. The fund acquired an additional 1,54,556 shares through market transactions on October 29, 2025, bringing their total holding to 71,06,458 shares. This acquisition was reported under SEBI substantial acquisition regulations and involved 11 different Motilal Oswal Mutual Fund schemes.

13Sept 25

Aceso Company Sells 5.65% Stake in HealthCare Global Enterprises

Aceso Company Pte. Ltd. has sold 79,66,310 equity shares (5.65%) of Healthcare Global Enterprises Limited (HCG) through on-market transactions. The sale occurred over two days, reducing Aceso's holding from 5.72% to 0.006%. HCG also announced the allotment of 15,84,730 equity shares under its Employee Stock Option Schemes and appointed Mr. Gopi Lama as Head of Domestic Sales.

12Sept 25

HealthCare Global Enterprises Appoints Gopi Lama as Head of Domestic Sales

Healthcare Global Enterprises Limited (HCG) has appointed Mr. Gopi Lama as the new Head of Domestic Sales, effective September 15, 2025. The Board of Directors approved the appointment based on the Nomination and Remuneration Committee's recommendation. Mr. Lama brings over 30 years of healthcare experience, including 13 years in hospital operations. He has previously worked with major healthcare organizations like Apollo, Fortis, and Narayana Health. His achievements include driving cluster revenues beyond INR 700.00 crore and expertise in sales operations and brand strategy.

11Sept 25

Morgan Stanley, Nippon India MF Lead Rs 438 Crore Share Purchase in HealthCare Global

Morgan Stanley, Nippon India Mutual Fund, Motilal Oswal MF, and Plutus Wealth Management collectively purchased 63 lakh equity shares (4.52% stake) of Healthcare Global Enterprises (HCG) for Rs 438.00 crore. The shares were priced at Rs 695.00 each on the National Stock Exchange. CVC Capital Partners' affiliate, Aceso Company Pte Ltd, was the seller, reducing its holding from 8.76% to 4.24%. This transaction follows KKR's recent agreement to acquire up to 54% stake in HCG from CVC Capital Partners for approximately USD 400 million.

10Sept 25

Aceso Company Offloads 6% Stake in HealthCare Global for ₹552 Crore

Aceso Company, part of the CVC Network, sold nearly 6% stake in Healthcare Global Enterprises (HCG) through a block deal on NSE, valued at ₹552.00 crore at ₹695.00 per share. Key buyers included Nippon India Mutual Fund, Plutus Wealth Management, Axis Mutual Fund, and Morgan Stanley Asia Singapore. This follows CVC Capital's earlier exit, reducing Aceso's stake from 60.4% to 8.8%. HCG shares have rallied 42% year-to-date, outperforming the NSE 500 index. The company reported a net profit of ₹44.00 crore on revenues of ₹2,223.00 crore in its latest results. Analysts maintain a positive outlook, with Ambit Capital setting a 12-month target price of ₹860.00.

22Aug 25

HCG Eyes 20% Margin Target as KKR Acquires Majority Stake; Promoter Reduces Shareholding

Healthcare Global Enterprises (HCG) aims to achieve a 20% margin target by the last quarter of the current financial year. The company reported 15% growth and is expanding through a hub-and-spoke model. KKR has acquired a 44-54% stake in HCG from CVC Asia V in a $400 million deal, reshaping the ownership structure. HCG recently acquired MG Hospital in Vijayawada and is now in a consolidation phase. The company's market cap stands at ₹9,386.00 crore, with shares trading at ₹672.95, gaining 73% over the past year. Promoter Dr. B.S. Ajaikumar has sold 13,92,000 equity shares, reducing his stake from 6.84% to 5.84%.

12Aug 25

HealthCare Global Enterprises Shareholders Approve Board Changes and New Articles of Association

Healthcare Global Enterprises Limited (HCG) shareholders approved several key resolutions via postal ballot. Changes include appointing Dr. B.S. Ajaikumar as Non-Executive Director and Chairman, adding new Non-Executive and Executive Directors, and appointing an Independent Director. Shareholders also approved amended Articles of Association and consultancy agreements with Dr. Ajaikumar and Mrs. Rossi. The voting saw strong participation, with most resolutions receiving over 90% approval and representing 84.93% of the company's total paid-up equity capital.

01Jul 25

Karnataka Government Calls for Probe into Alleged Unfair Clinical Trials at HCG Bengaluru

The Karnataka government has requested the Drug Controller General of India (DCGI) to investigate alleged unfair clinical trials at Healthcare Global Enterprises Ltd's (HCG) Bengaluru facility. The inquiry was prompted by concerns raised by a former chairperson of HCG's Institutional Ethics Committee regarding patient safety, regulatory compliance, and institutional integrity in clinical trials. This development could have significant implications for HCG, a prominent cancer care provider, potentially affecting its reputation and regulatory standing.

10Jun 25

Healthcare Global Enterprises Unveils Ambitious Expansion Plan

Healthcare Global Enterprises (HCG) plans to add 1,000 beds over the next three years through a hybrid expansion model. The company aims to maintain a 20% EBITDA margin despite expansion. HCG reported 18% year-on-year revenue growth but a 65% decline in Profit After Tax. The company projects 15% overall revenue growth over the next three years.

09Jun 25

Healthcare Global Targets 19-20% Profit Margins in Efficiency Drive

Healthcare Global Enterprises Ltd, a major player in the Indian healthcare sector, has announced a strategic goal to maintain profit margins between 19% and 20%. This target demonstrates the company's commitment to financial stability and operational efficiency in the face of industry challenges. The focus on sustaining these margins suggests potential initiatives in cost management, resource optimization, and service delivery improvements. This financial objective provides a clear benchmark for stakeholders and reflects the company's confidence in its business model.

26May 25

Healthcare Global Enterprises Ltd Reports Mixed Q4 Financial Results

Healthcare Global Enterprises Ltd announced Q4 results with mixed performance. Consolidated revenue increased 18.26% year-over-year to ₹5.83 billion. However, net profit declined 71.37% to ₹67 million compared to the same quarter last year. Sequential growth showed 4.67% increase in revenue but 12.99% decrease in profit from the previous quarter.

02May 25

CCI Greenlights KKR's Share Acquisition in Healthcare Global Enterprises

The Competition Commission of India (CCI) has approved a proposed share acquisition in Healthcare Global Enterprises Limited by KKR, through its entities Hector Asia Holdings and KIA EBT II Scheme. This approval allows KKR, a global investment firm, to proceed with its investment in the prominent Indian healthcare company. While specific details of the acquisition remain undisclosed, this development could potentially reshape Healthcare Global Enterprises' future operations and strategic direction.

01May 25

CCI Greenlights KKR's Acquisition of Healthcare Global Enterprises

The Competition Commission of India (CCI) has approved KKR's proposed acquisition of Healthcare Global Enterprises Limited, a specialist in oncology care. The purchase will be executed through KKR's entities Hector Asia Holdings and KIA EBT II Scheme. This approval is a crucial step in KKR's expansion strategy in the Indian healthcare market, subject to additional regulatory approvals and closing conditions. While financial details are undisclosed, the acquisition could bring global expertise and capital to Healthcare Global Enterprises, potentially impacting India's healthcare industry landscape.

24Feb 25

KKR to Acquire Controlling Stake in HealthCare Global Enterprises for ₹3,428 Crore

Global investment firm KKR is set to acquire a controlling stake of up to 54% in HealthCare Global Enterprises Ltd (HCG), India's largest cancer care provider, for ₹3,428 crore ($400 million). The deal involves a two-tranche acquisition at ₹445 per share, with an open offer to public shareholders at ₹504.41 per share. HCG's founder, Dr. BS Ajaikumar, will transition to Non-Executive Chairman. The transaction, expected to close by Q3 2025, is subject to regulatory approvals and aims to support the development of medical infrastructure and oncology services in India.